EA201291179A1 - Органические пероксидные соединения для инактивации микроорганизмов - Google Patents

Органические пероксидные соединения для инактивации микроорганизмов

Info

Publication number
EA201291179A1
EA201291179A1 EA201291179A EA201291179A EA201291179A1 EA 201291179 A1 EA201291179 A1 EA 201291179A1 EA 201291179 A EA201291179 A EA 201291179A EA 201291179 A EA201291179 A EA 201291179A EA 201291179 A1 EA201291179 A1 EA 201291179A1
Authority
EA
Eurasian Patent Office
Prior art keywords
organic peroxide
inactivation
microorganisms
connections
inactivators
Prior art date
Application number
EA201291179A
Other languages
English (en)
Inventor
Йенс Петер Грегерзен
Томас Грундеманн
Original Assignee
Новартис Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Новартис Аг filed Critical Новартис Аг
Publication of EA201291179A1 publication Critical patent/EA201291179A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/02—Acyclic compounds
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N35/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical
    • A01N35/02—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical containing aliphatically bound aldehyde or keto groups, or thio analogues thereof; Derivatives thereof, e.g. acetals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/24—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with two or more hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12061—Methods of inactivation or attenuation
    • C12N2720/12063—Methods of inactivation or attenuation by chemical treatment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16061—Methods of inactivation or attenuation
    • C12N2760/16063—Methods of inactivation or attenuation by chemical treatment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16161—Methods of inactivation or attenuation
    • C12N2760/16163—Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Environmental Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polymerization Catalysts (AREA)

Abstract

Многофункциональные органические пероксиды применяют в качестве микробиологических инактиваторов и/или для деградации нуклеиновых кислот. Они включают по меньшей мере один атом углерода и по меньшей мере две органические пероксидные группы. Инактиватором идеально является гидропероксид. Изобретение, в частности, является применимым во время получения вирусных вакцин.
EA201291179A 2010-05-06 2011-05-06 Органические пероксидные соединения для инактивации микроорганизмов EA201291179A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39511710P 2010-05-06 2010-05-06
PCT/IB2011/001394 WO2011138682A2 (en) 2010-05-06 2011-05-06 Organic peroxide compounds for microorganism inactivation

Publications (1)

Publication Number Publication Date
EA201291179A1 true EA201291179A1 (ru) 2013-04-30

Family

ID=44532956

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201291179A EA201291179A1 (ru) 2010-05-06 2011-05-06 Органические пероксидные соединения для инактивации микроорганизмов

Country Status (11)

Country Link
US (1) US9426989B2 (ru)
EP (1) EP2566323A2 (ru)
JP (1) JP6072677B2 (ru)
KR (1) KR20130079398A (ru)
CN (1) CN102946727B (ru)
AU (1) AU2011249487C1 (ru)
BR (1) BR112012028146A2 (ru)
CA (1) CA2796213A1 (ru)
EA (1) EA201291179A1 (ru)
MX (1) MX343948B (ru)
WO (1) WO2011138682A2 (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8906963B2 (en) 2011-07-14 2014-12-09 Ecolab Usa Inc Deodorization of peracids
US8883848B2 (en) 2011-07-14 2014-11-11 Ecolab Usa Inc. Enhanced microbial peracid compositions and methods of use at reduced temperatures in aseptic cleaning
GB2495341B (en) 2011-11-11 2013-09-18 Novartis Ag Fermentation methods and their products
ITUA20162517A1 (it) * 2016-04-12 2017-10-12 Andrea Fantozzi Composizione per la conservazione/fissazione di materiale biologico
CN110804641A (zh) * 2019-09-04 2020-02-18 中国农业科学院兰州兽医研究所 一种比较分析不同牛支原体菌株毒力的方法
BR112022008711A2 (pt) 2019-11-07 2022-07-19 Seqirus Uk Ltd Métodos para produzir uma vacina viral e reduzir o tamanho da partícula viral

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL127618C (ru) * 1963-01-16
US3560395A (en) * 1968-09-12 1971-02-02 Pennwalt Corp Aqueous ketone peroxide-hydrogen peroxide composition
US4060644A (en) * 1976-02-09 1977-11-29 Interox Chemicals Limited Bleaching
DE2933498A1 (de) 1979-08-18 1981-04-09 Dr.rer.nat. Hans-Dieter 4234 Alpen Deppe Chemothermisches desinfektions- und sterilisationsverfahren
PH25669A (en) * 1985-12-19 1991-09-04 Padmini Sampathkumar Anaerobe-selective antibacterial compositions, methods
EP0461700A1 (en) 1990-06-12 1991-12-18 Akzo Nobel N.V. Aqueous disinfectant compositions, and concentrates for preparing the same
US5437868A (en) 1991-07-23 1995-08-01 Ecolab Inc. Peroxyacid antimicrobial composition
GB9222561D0 (en) * 1992-10-27 1992-12-09 Ici Plc Macromolecular degradation
US5824536A (en) * 1994-08-23 1998-10-20 St. Jude Children's Research Hospital Influenza virus replicated in mammalian cell culture and vaccine production
FR2738127B1 (fr) 1995-08-30 1998-03-27 Oreal Applicateur de mascara
DE19612966B4 (de) 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
GB9612035D0 (en) * 1996-06-08 1996-08-07 Oilfield Chemical Additives Li Method of inhibiting reservoir souring by bacteria
DE19817743A1 (de) * 1998-04-21 1999-10-28 Binker Materialschutz Gmbh Materialschutzmittel
AU758625B2 (en) * 1998-08-20 2003-03-27 Ecolab Inc. The treatment of meat products
PL355287A1 (en) 1999-09-24 2004-04-05 Smithkline Beecham Biologicals S.A. Intranasal influenza virus vaccine
DE60142506D1 (de) 2000-03-03 2010-08-19 Chemo Sero Therapeut Res Inst In serumfreier kultur verwendbare zelle, kultursuspension und verfahren zur virusproduktion als impfstoff unter verwendung der zelle
FR2808803B1 (fr) 2000-05-11 2004-12-10 Agronomique Inst Nat Rech Cellules es modifiees et gene specifique de cellules es
GB0024089D0 (en) 2000-10-02 2000-11-15 Smithkline Beecham Biolog Novel compounds
US20020107288A1 (en) * 2000-12-08 2002-08-08 Singh Waheguru Pal Methods of sterilizing with dipercarboxylic acids
US7316824B2 (en) 2000-12-15 2008-01-08 Ecolab Inc. Method and composition for washing poultry during processing
EP1361889A1 (en) 2001-02-23 2003-11-19 GlaxoSmithKline Biologicals S.A. Novel vaccine
PT1361890E (pt) 2001-02-23 2011-06-07 Glaxosmithkline Biolog Sa Formulações vacinais de influenza para distribuição intradérmica
MY134424A (en) 2001-05-30 2007-12-31 Saechsisches Serumwerk Stable influenza virus preparations with low or no amount of thiomersal
US20030012804A1 (en) * 2001-06-22 2003-01-16 Aquacide And Use Aquacide and use
JPWO2003014338A1 (ja) * 2001-08-02 2004-11-25 アンジェスＭｇ株式会社 不活性化ウイルスエンベロープの製造方法
DE10144903A1 (de) 2001-09-12 2003-03-27 Chiron Behring Gmbh & Co Vermehrung von Viren in Zellkultur
DE10144906B4 (de) 2001-09-12 2013-11-28 Novartis Vaccines And Diagnostics Gmbh Verfahren zur großtechnischen Herstellung von Impfstoffen
FR2832423B1 (fr) 2001-11-22 2004-10-08 Vivalis Systeme d'expression de proteines exogenes dans un systeme aviaire
CN1194984C (zh) * 2002-02-04 2005-03-30 中国农业科学院植物保护研究所 一种抗生素及其制备方法和应用
FR2836924B1 (fr) 2002-03-08 2005-01-14 Vivalis Lignees de cellules aviaires utiles pour la production de substances d'interet
JP4299514B2 (ja) * 2002-08-29 2009-07-22 長谷川香料株式会社 抗菌抗カビ剤
DE10306018A1 (de) * 2003-02-13 2004-09-09 Siemens Ag Analyse- und Diagnostikinstrument
JP2006523657A (ja) * 2003-04-16 2006-10-19 ネオケミカル デザロージョス アバンサードス，ソシエダ アノニマ 殺生物剤：殺菌剤、防腐剤、消毒剤及び駆虫剤としてのジアルキルケトンペルオキシドの使用
EP1528101A1 (en) 2003-11-03 2005-05-04 ProBioGen AG Immortalized avian cell lines for virus production
WO2005113756A1 (en) 2004-05-14 2005-12-01 Glaxosmithkline Biologicals S.A. Method
CN101094915A (zh) 2004-05-20 2007-12-26 益得生物医学公司 生产流感疫苗的方法
EP1831353B1 (en) 2004-12-23 2012-02-29 MedImmune, LLC Non-tumorigenic mdck cell line for propagating viruses
GB0505909D0 (en) 2005-03-23 2005-04-27 Univ Leeds Formulations
FR2884255B1 (fr) 2005-04-11 2010-11-05 Vivalis Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe
WO2008039171A2 (en) * 2005-08-08 2008-04-03 Oregon Health & Science University Inactivating pathogens with hydrogen peroxide for vaccine production
WO2007042175A1 (en) * 2005-10-07 2007-04-19 Dsm Ip Assets B.V. Peroxide decomposition catalyst
NZ567817A (en) 2005-11-01 2012-01-12 Novartis Vaccines & Diagnostic Cell-derived viral vaccines with low levels of residual cell DNA by beta-propiolactone treatment
ES2286949B1 (es) * 2006-05-26 2008-11-01 Braulio Peña Rodriguez Uso de combinaciones de peroxido de metil etil cetona por pulverizacion.
NZ577405A (en) 2006-12-06 2012-08-31 Novartis Ag Vaccines including antigen from four strains of influenza virus

Also Published As

Publication number Publication date
AU2011249487A1 (en) 2012-09-27
MX343948B (es) 2016-11-30
CN102946727B (zh) 2015-08-19
CN102946727A (zh) 2013-02-27
KR20130079398A (ko) 2013-07-10
AU2011249487B2 (en) 2014-10-02
EP2566323A2 (en) 2013-03-13
US9426989B2 (en) 2016-08-30
WO2011138682A3 (en) 2012-03-15
AU2011249487C1 (en) 2015-05-14
BR112012028146A2 (pt) 2015-09-15
WO2011138682A8 (en) 2012-07-19
WO2011138682A2 (en) 2011-11-10
JP6072677B2 (ja) 2017-02-01
CA2796213A1 (en) 2011-11-10
JP2013528586A (ja) 2013-07-11
US20130149194A1 (en) 2013-06-13
MX2012012335A (es) 2012-11-21

Similar Documents

Publication Publication Date Title
EA201291179A1 (ru) Органические пероксидные соединения для инактивации микроорганизмов
PH12015501953A1 (en) Substituted nucleotide analogs
PH12015501017A1 (en) Alternative uses for hbv assembly effectors
EA030115B9 (ru) Новые 6-конденсированные гетероарилдигидропиримидины для лечения и профилактики заражения вирусом гепатита b
EA025278B9 (ru) Антивирусная композиция против заключенных или незаключенных в оболочку днк- или рнк-вирусов
WO2011133722A3 (en) Anti-viral compounds
CY1116383T1 (el) Αντιβακτηριακες ενωσεις
WO2011049987A3 (en) Azaindazoles to treat flaviviridae virus infection
MA33894B1 (fr) Procedes d'administration therapeutique de la pirferidone
TR201813877T4 (tr) Spi̇nal müsküler atrofi̇ni̇n tedavi̇ edi̇lmesi̇ne yöneli̇k bi̇leşi̇kler.
WO2011133728A3 (en) Anti-viral compounds
CY1111378T1 (el) Προερχομενα απο κυτταρα ιικα εμβολια με χαμηλα επιπεδα υπολειμματικου κυτταρικου dna
WO2011133729A3 (en) Anti-viral compounds
EP2588121A4 (en) C5A ANALOGUES AND METHODS OF USE THEREOF
NZ603527A (en) Vaccines comprising cholesterol and cpg as sole adjuvant - carrier molecules
MY161252A (en) Viral inactivation using improved solvent-detergent method
UY32715A (es) Combinaciones farmacéuticas útiles para el tratamiento del virus de la hepatitis c (vhc), usos y métodos relacionados
IN2014KN02769A (ru)
UY34420A (es) ?métodos de tratamiento del virus de la hepatitis c con que de gs-7977 y ribavirina, composiciones y usos"
WO2012037116A3 (en) Genetic variations associated with common variable immunodeficiency (cvid) and methods of use thereof
WO2011133707A3 (en) Anti-viral compounds
BR112021025116A2 (pt) Células linfocíticas ativadas e métodos de uso das mesmas para tratar câncer e condições infecciosas
NI201700080A (es) Composiciones de vacuna para el virus del dengue y métodos de uso de las mismas.
WO2012154271A3 (en) Method and cells for identifying rig-i pathway regulators
PL400501A1 (pl) Sposób izolowania DNA drobnoustrojów z krwi